Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/2010
09/21/2010CA2445068C Azo compounds for type i phototherapy
09/21/2010CA2440559C Novel non-imidazole compounds
09/21/2010CA2438593C Glucopyranosyloxypyrazole derivatives and medicinal use thereof
09/21/2010CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
09/21/2010CA2434178C Substituted amine derivatives and methods of use
09/21/2010CA2429308C Novel lactam-substituted pyrazolopyridine derivatives
09/21/2010CA2428019C Estrogen receptor modulators
09/21/2010CA2417148C Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
09/21/2010CA2408746C Antisense phosporodiamidate morpholino oligonucleotide inhibition of cytochrome p450 to modulate drug pharmacokinetics
09/21/2010CA2401502C Carboxylic acid derivatives as ip antagonists
09/21/2010CA2396045C Aqueous ionic solutions and their uses in particular in ophthalmology
09/21/2010CA2387539C Method for protecting normal cells from cytotoxicity of chemotherapeutic agents
09/21/2010CA2386549C Polymorphic b form of 3-(cyclopropylmethoxy)-4-[4-(methylsulfonyl)phenyl]-5,5-dimethyl-5h-furan-2-one
09/21/2010CA2384880C Methods for making recombinant proteins using apoptosis inhibitors
09/21/2010CA2376943C Use of creatine or creatine compounds for skin preservation
09/21/2010CA2376916C Anaesthetic formulation comprising an nmda-antagonist and an alpha-2 adrenergic agonist
09/21/2010CA2359948C Triazole compounds with dopamine-d3-receptor affinity
09/21/2010CA2343074C Akt nucleic acids, polypeptides, and uses thereof
09/21/2010CA2338073C Novel urokinase inhibitors
09/21/2010CA2251655C In vivo gene transfer methods for wound healing
09/21/2010CA2234941C Delivery of biologically active polypeptides
09/16/2010WO2010104571A2 Treating chronic fatigue syndrome and prolonged qt interval
09/16/2010WO2010104195A1 Novel isoindolin-1-one derivative
09/16/2010WO2010104176A1 Mega-phosphoprotein cleavage inhibitor
09/16/2010WO2010104114A1 Method for preparing polypeptide library
09/16/2010WO2010104056A1 Lifespan-extending agent
09/16/2010WO2010104035A1 Method for predicting therapeutic efficacy of chemotherapy on non-small-cell lung cancer
09/16/2010WO2010104024A1 Piperazine compound capable of inhibiting prostaglandin d synthase
09/16/2010WO2010103851A1 Method for determining sensitivity to irinotecan and use thereof
09/16/2010WO2010102972A1 Plasma-adapted full electrolyte solution
09/16/2010WO2010102512A1 C-aryl glucoside derivatives, preparation process and pharmaceutical use thereof
09/16/2010US20100234599 Method for preparing acid addition salts of polyacidic basic compounds
09/16/2010US20100234466 Compositions and Methods for Reducing Body Fat
09/16/2010US20100234454 Treatment of cnidaria intoxication
09/16/2010US20100234444 Hindered ester-based biodegradable linkers for oligonucleotide delivery
09/16/2010US20100234430 Methods and pharmaceutical formulations for protecting pharmaceutical compounds from acidic environments
09/16/2010US20100234415 Indole derivatives as crth2 receptor antagonists
09/16/2010US20100234368 Condensed ring compound and use thereof
09/16/2010US20100234359 Treatment of sleep disorders
09/16/2010US20100234353 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
09/16/2010US20100234350 Platelet adp receptor inhibitors
09/16/2010US20100234333 Novel quinuclidine derivatives and medicinal compositions containing the same
09/16/2010US20100234332 Novel quinuclidine derivatives and medicinal compositions containing the same
09/16/2010US20100234320 Emulsifying compositions based on alkyl polyglycosides and esters
09/16/2010US20100234308 Wake-up remedy
09/16/2010US20100234304 Beta sheet tapes ribbons in tissue engineering
09/16/2010US20100234284 Pharmaceutical compositions based on NK2 antagonists for pediatric use
09/16/2010US20100233819 Robo: a novel family of polypeptides and nucleic acids
09/16/2010US20100233297 Systemic administration of nac as an adjunct in the treatment of terrorism exposures such as radiation and for prophylaxis
09/16/2010US20100233281 Process for decreasing environmental pollutants in an oil or a fat.
09/16/2010US20100233238 Medical Devices Having Nanoporous Coatings for Controlled Therapeutic Agent Delivery
09/16/2010US20100233228 Drug-Eluting Medical Device
09/16/2010US20100233225 Method of surface coating devices to incorporate bioactive molecules
09/16/2010US20100233193 Systemic administration of nac for vaccination prophylaxis
09/16/2010US20100233184 Methods of reducing phosphate absorption
09/16/2010US20100233169 Methods for treating obesity using fibroblast growth factor-Like polypeptides
09/16/2010US20100233152 Use of HMGB proteins and nucleic acids that code therefor
09/16/2010US20100233140 Collagen-containing cell carrier
09/16/2010US20100233139 Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
09/16/2010US20100233136 Isolated populations of cells and methods of generating and using same
09/16/2010US20100233124 Bacillus based delivery system and methods of use
09/16/2010US20100233097 Contrast agents
09/16/2010US20100233090 Targeting vector-phospholipid conjugates
09/16/2010DE10336778B4 Stabilisierung eines Patienten mit einem xenonhaltigen Gas Stabilizing a patient with a xenon-containing gas
09/16/2010CA2754688A1 Novel isoindolin-1-one derivative
09/16/2010CA2754613A1 Piperazine compound capable of inhibiting prostaglandin d synthase
09/16/2010CA2753498A1 Plasma-adapted balanced electrolyte solution
09/15/2010EP2228654A2 Diagnosis and prevention of cancer cell invasion
09/15/2010EP2228389A2 Antibodies against vascular endothelial growth factor 2
09/15/2010EP2228378A1 Monosebacate of pyrazole derivative
09/15/2010EP2228376A1 Pyripyropene derivative having acat2-inhibiting activity
09/15/2010EP2228364A1 Acylsulfonamides as inhibitors of steroid sulfatase
09/15/2010EP2228068A1 Therapeutic agent for cerebral ischemic injury
09/15/2010EP2228065A2 Heterocyclo inhibitors of potassium channel function
09/15/2010EP2228062A1 Compositions containing a phospholipid-curcumin complex and piperine as chemosensitizing agent
09/15/2010EP2227232A1 Methods for inhibiting t helper cell differentiation
09/15/2010EP1758596B9 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
09/15/2010EP1611144B1 Derivatives of 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl phosphonic acid and their use as n-methyl-d-aspartate (nmda) recetor antagonists
09/15/2010EP1536839B1 Combination therapy comprising omega-interferon for treating infection with hepatitis c virus or yellow fever virus
09/15/2010EP1501819B1 Estrogen receptor modulators
09/15/2010EP1351681B1 Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
09/15/2010EP1303596B1 Morpholino antisense oligomers as enzyme inhibitors for improving pharmacokinetics of a drug
09/15/2010CN1907321B Medicinal composition for treating exterior deficiency and preparation method thereof
09/15/2010CN101835892A CDCA1 peptide and pharmaceutical agent comprising the same
09/15/2010CN101835792A FOXM1 peptide and medicinal agent comprising the same
09/15/2010CN101835763A Oxadiazolidinedione compound
09/15/2010CN101835737A Spiro-ring compound and use thereof for medical purposes
09/15/2010CN101835728A Compounds for use in imaging, diagnosing, and/or treatment of diseases of the central nervous system or of tumors
09/15/2010CN101835491A Agent for promoting corneal endothelial cell adhesion
09/15/2010CN101835480A Ligand agent for peroxisome proliferator-activated receptor (PPAR)
09/15/2010CN101830896A Organic acid salt of optical isomer of penehyclidine
09/15/2010CN101830889A 嘧啶衍生物 Pyrimidine derivatives
09/15/2010CN101829325A Pharmaceutical composition for treatment of diseases caused by IL-6 production
09/15/2010CN101829235A Traditional Chinese medicine composition for treating postoperative fatigue syndromes and preparation method thereof
09/15/2010CN101829145A Elk horn active site and preparation method and application thereof
09/15/2010CN101829143A Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate
09/15/2010CN101829131A Application of ginsenoside Rg1 in healthcare products
09/15/2010CN101829120A Composition for treatment of external secretion disorders
09/15/2010CN101829079A Application of compound of (E)-5-[6-hydroxy-5-(3-methyl-1-butenyl)-2-benzofuranyl] phenyl-1, 3-diol to preparation of pancrelipase inhibitor
09/15/2010CN101829066A Fructose diphosphate sodium tablet
1 ... 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 ... 1564